Darnatein Set to Showcase Innovations at the International BMP Conference Focused on Regenerative Medicine Darnatein, a subsidiary of OSR Holdings Inc., will present breakthroughs in regenerative biologics at the BMP Conference, showcasing their innovative BMP chimeras.

Darnatein Set to Showcase Innovations at the International BMP Conference Focused on Regenerative Medicine #United_States #Philadelphia #OSR_Holdings #Darnatein #BMP_Conference

Darnatein Expands Global Reach for Osteoarthritis Treatment with New Patent Darnatein furthers its global strategy by securing an international patent for its osteoarthritis treatment technology, enhancing future potential.

Darnatein Expands Global Reach for Osteoarthritis Treatment with New Patent #South_Korea #Seoul #Patent #Osteoarthritis #Darnatein